Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2022

Genmab — Maj 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #1208

    Nyt TA købssignal https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/103704_Skaermbillede_2022_05_26_075408_2648.jpg

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #1209

      God morgen. 🙂

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #1210

        USA/lukning: Pæne stigninger efter neutralt Fed-referat https://www.proinvestor.com/investornyt/829520/usa-lukning-paene-stigninger-efter-neutralt-fed-referat

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #1211

          USA/T-bond: Uændrede renter efter nyhedsfattigt Fed-referat
          https://www.proinvestor.com/investornyt/829563/usa-t-bond-uaendrede-renter-efter-nyhedsfattigt-fed-referat

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bibob
            wrote on sidst redigeret af
            #1212

            Cancer killing oncolytic virus. https://www.biospace.com/article/first-patient-dosed-with-imugene-s-cancer-killing-oncolytic-virus-drug-/

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #1213

              Her kan i signe in til newsletters from ASCO. Fierce Pharma https://firstwordpharma.com/my-account/newsletters

              1 Reply Last reply
              0
              • B Offline
                B Offline
                BioShare
                wrote on sidst redigeret af
                #1214

                https://ir.genmab.com/news-releases/news-release-details/genmab-announces-multiple-abstracts-be-presented-2022-american

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #1215

                  God morgen. 🙂

                  1 Reply Last reply
                  0
                  • T Offline
                    T Offline
                    transalp
                    wrote on sidst redigeret af
                    #1216

                    Go morgen.. 🙂

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #1217

                      God morgen. 🙂

                      1 Reply Last reply
                      0
                      • BudweisB Offline
                        BudweisB Offline
                        Budweis
                        wrote on sidst redigeret af
                        #1218

                        God morgen. Første sammenligning https://twitter.com/bertrandbio/status/1529938502212894724?s=21&t=nWn3U3cGuOiNogcj4OT9Zg

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #1219

                          Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting https://www.proinvestor.com/investornyt/830162/genmab-announces-multiple-abstracts-to-be-presented-at-the-2022-american-society-of-clinical-oncology-asco-annual-meeting

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #1220

                            Epco+R-CHOP i 1. linje dlbcl ser stærk ud. https://meetings.asco.org/abstracts-presentations/210249

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #1221

                              Sammenligningen glofi/epco falder da vist ud til epcos fordel.

                              1 Reply Last reply
                              0
                              • nohopeN Offline
                                nohopeN Offline
                                nohope
                                wrote on sidst redigeret af
                                #1222

                                Jeg synes også tallene er i Epco favør, men der er vel ikke tale om knockout effect.

                                1 Reply Last reply
                                0
                                • nohopeN Offline
                                  nohopeN Offline
                                  nohope
                                  wrote on sidst redigeret af
                                  #1223

                                  Glofi smider ikke håndklædet i ringen på det her grundlag.

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #1224

                                    Det er på alle 3 parametre. Mere syge i epco (flere post car-t og flere tidligere linjer)
                                    , mildere CRS og bedre effekt

                                    1 Reply Last reply
                                    0
                                    • nohopeN Offline
                                      nohopeN Offline
                                      nohope
                                      wrote on sidst redigeret af
                                      #1225

                                      Epco er The Great White Hope. Den skal levere knockout.

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        deleted-user
                                        wrote on sidst redigeret af
                                        #1226

                                        Kan du ikke forklare mig, som uvidende pharma-mand, hvornår "knockout" er leveret i din optik, så har jeg lidt at måle med. Pft.

                                        1 Reply Last reply
                                        0
                                        • nohopeN Offline
                                          nohopeN Offline
                                          nohope
                                          wrote on sidst redigeret af
                                          #1227

                                          Det er ikke så meget mig der skal overbevises, det er Roche der skal miste lysten til at slås.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper